2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with chiniofon in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vavrek, MT; Weisburger, JH | 1 |
Luks, HJ; Roland, SF; Spratt, TE; Vavrek, MT; Weisburger, JH | 1 |
Edenharder, R; Platt, KL; Rauscher, R | 1 |
Hsu, FF; Lakshmi, VM; Zenser, TV | 1 |
4 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and chiniofon
Article | Year |
---|---|
Efficient method for the isolation by HPLC, of a major metabolite of the carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), the 5-hydroxy derivative.
Topics: Animals; Carcinogens; Chelating Agents; Chromatography, High Pressure Liquid; Feces; Glucuronidase; Hydroxyquinolines; Male; Quinolines; Rats; Rats, Inbred F344 | 1990 |
Identification of sulfate and glucuronic acid conjugates of the 5-hydroxy derivative as major metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline in rats.
Topics: Animals; Bile; Carcinogens; Chromatography, High Pressure Liquid; Hydroxyquinolines; Male; Quinolines; Rats; Rats, Inbred F344 | 1989 |
The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Topics: Animals; Antimutagenic Agents; Biotransformation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme System; Flavonoids; Hydroxylation; Hydroxyquinolines; Male; Microsomes, Liver; Mutagenicity Tests; Mutagens; Oxidoreductases; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1997 |
Characterization of new metabolites from in vivo biotransformation of 2-amino-3-methylimidazo[4,5-f]quinoline in mouse by mass spectrometry.
Topics: Animals; beta-Naphthoflavone; Carcinogens; Chromatography, High Pressure Liquid; Deuterium Exchange Measurement; Enzyme Induction; Female; Glucuronates; Glucuronides; Hydroxylation; Hydroxyquinolines; Imidazoles; Injections, Intraperitoneal; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Mice; Mice, Inbred C57BL; Molecular Structure; Oxidation-Reduction; Quinolines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Urine | 2009 |